NCX-278
NCX-278 is a human carbonic anhydrase inhibitor with a 13 nM Ki for hCA II, 410 nM Ki for hCA I, 181 nM Ki for hCA IV, and selective inhibition of hCA II over hCA IV. NCX-278 is a potent and effective stimulator of NO/sGC/cGMP signaling with an EC50 of 2.05 lM. NCX-278 exerts NO-mediated vascular relaxant effects. NCX-278 lowers intraocular pressure in normotensive rabbits. NCX-278 can be used for the research of open-angle glaucoma.
For research use only. We do not sell to patients.
- CAS No.: 1202697-61-7
- Formula: C14H21N3O9S3
- Molecular Weight:471.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
hCA II 13 nM (Ki) |
hCA I 410 nM (Ki) |
NCX-278 potently inhibits recombinant human hCA II with a Ki of 13 nM, and shows 13.9-fold selectivity for hCA II over hCA IV, while inhibiting hCA I with a Ki of 410 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | Tmax |
|---|---|---|---|
| Rat[1] | 55 mM | o.a. | 120 min |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:New Zealand white rabbits[1]
-
Dosage:55 mM
-
Administration:o.a.; single dose
-
Result:Reduced intraocular pressure to a maximal effect of -3.7 mmHg.
Reached peak effect at 120 minutes post-dosing.
Returned to basal intraocular pressure levels at 360 minutes post-dosing.
Chemical Information
-
CAS No. 1202697-61-7
-
Molecular Weight 471.53
-
Formula C14H21N3O9S3
-
SMILES
O=C(OCCCO[N+]([O-])=O)N([C@@H]1C2=C(S(=O)([C@H](C1)C)=O)SC(S(N)(=O)=O)=C2)CC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)